Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2018

Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2018


  • Products Id :- GDME0575EPD
  • |
  • Pages: 138
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Abdominal Aortic Stent Grafts-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Abdominal Aortic Stent Grafts-Medical Devices Pipeline Assessment, 2018 provides an overview of Abdominal Aortic Stent Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Abdominal Aortic Stent Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Abdominal Aortic Stent Grafts under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Abdominal Aortic Stent Grafts and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Abdominal Aortic Stent Grafts under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 8

2 Introduction 9

2.1 Abdominal Aortic Stent Grafts Overview 9

3 Products under Development 10

3.1 Abdominal Aortic Stent Grafts-Pipeline Products by Stage of Development 10

3.2 Abdominal Aortic Stent Grafts-Pipeline Products by Territory 11

3.3 Abdominal Aortic Stent Grafts-Pipeline Products by Regulatory Path 13

3.4 Abdominal Aortic Stent Grafts-Pipeline Products by Estimated Approval Date 14

3.5 Abdominal Aortic Stent Grafts-Ongoing Clinical Trials 15

4 Abdominal Aortic Stent Grafts-Pipeline Products under Development by Companies 16

4.1 Abdominal Aortic Stent Grafts Companies-Pipeline Products by Stage of Development 16

4.2 Abdominal Aortic Stent Grafts-Pipeline Products by Stage of Development 17

5 Abdominal Aortic Stent Grafts Companies and Product Overview 19

5.1 Altura Medical Inc Company Overview 19

5.1.1 Altura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.2 BiFlow Medical Ltd Company Overview 22

5.2.1 BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

5.3 Cook Medical Inc Company Overview 23

5.3.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.4 Cordis Corp Company Overview 27

5.4.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 27

5.5 Cytograft Tissue Engineering Inc (Inactive) Company Overview 30

5.5.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30

5.6 Endologix Inc Company Overview 31

5.6.1 Endologix Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.7 Endoluminal Sciences Pty Ltd. Company Overview 44

5.7.1 Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview 44

5.8 Hadassah Medical Center Company Overview 45

5.8.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 45

5.9 Kawasumi Laboratories Inc Company Overview 46

5.9.1 Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.10 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 47

5.10.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

5.11 Lombard Medical Technologies Inc. Company Overview 49

5.11.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 49

5.12 Lombard Medical Technologies Ltd Company Overview 51

5.12.1 Lombard Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

5.13 Medtronic plc Company Overview 55

5.13.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 55

5.14 MicroPort Scientific Corp Company Overview 58

5.14.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 58

5.15 St. Jude Medical LLC Company Overview 59

5.15.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 59

5.16 Terumo Aortic Company Overview 60

5.16.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview 60

5.17 TriVascular Inc Company Overview 67

5.17.1 TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview 67

5.18 University of Colorado Denver Company Overview 72

5.18.1 University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview 72

5.19 University of Limerick Company Overview 73

5.19.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 73

5.20 Venus MedTech Company Overview 74

5.20.1 Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview 74

5.21 W. L. Gore & Associates Inc Company Overview 75

5.21.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview 75

6 Abdominal Aortic Stent Grafts- Recent Developments 78

6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 78

6.2 May 22, 2018: UT Southwestern surgeons among world's first to repair aortic arch aneurysm with leading-edge technique 80

6.3 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC 81

6.4 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow 82

6.5 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 82

6.6 May 04, 2018: Ross Harvey named new director of global Customer Support & Delivery at Cook Medical 82

6.7 May 02, 2018: Endologix Announces First Quarter 2018 Financial Results 83

6.8 May 02, 2018: Endologix Names John Onopchenko As Chief Executive Officer 84

6.9 Apr 26, 2018: Vizient Names David F. Ertel as New Chief Financial Officer 84

6.10 Apr 25, 2018: Endovascular Aneurysm Sealing (EVAS) with Nellix System Associated with Higher Survival than Traditional Endovascular Aneurysm Repair (EVAR) in New Study 85

6.11 Apr 25, 2018: LeMaitre Q1 2018 Sales USD26.0mm (+8%), EPS USD0.19 (+17%) 86

6.12 Apr 25, 2018: 2018 Vizient Connections Summit to Focus on Maximizing Supply Chain Operations and Pharmacy Performance 87

6.13 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 87

6.14 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 88

6.15 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 88

6.16 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 90

6.17 Mar 21, 2018: Endospan Receives CE Mark for HORIZON EVAR System Based on Robust Clinical and Pivotal Data to Treat Abdominal Aortic Aneurysm (AAA) 91

6.18 Mar 19, 2018: Endologix Reports Positive Results from Global ENCORE Analysis with Polymer Endovascular Aneurysm Repair (EVAR) Using Ovation Abdominal Stent Graft Systems 91

6.19 Mar 05, 2018: Endologix Announces Enrollment of the First Patient in EVAS2 IDE Clinical Study of the Nellix EndoVascular Aneurysm Sealing System 91

6.20 Feb 21, 2018: LeMaitre Reports Net Income Of USD4.3mm In Q4 2017 92

6.21 Feb 21, 2018: Endologix Reports Fourth Quarter and Fiscal Year 2017 Financial Results 93

6.22 Feb 21, 2018: Endologix Announces Resignation Of John McDermott As Chief Executive Officer 94

6.23 Feb 12, 2018: Vizient Named as a 2018 World's Most Ethical Company by the Ethisphere Institute 94

6.24 Feb 08, 2018: MicroPort Endovascular Hercules Series Products Gain Regulatory Approval in Colombia 95

6.25 Feb 08, 2018: Joint development agreement for Japan's first abdominal aortic aneurysm stent graft 96

6.26 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 97

6.27 Feb 05, 2018: Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study 97

6.28 Feb 05, 2018: Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study 97

6.29 Feb 04, 2018: Byron Jobe Leads Vizient as New President and CEO 98

6.30 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 98

6.31 Jan 29, 2018: Endologix Names Greg Morrow As Chief Marketing Officer 99

6.32 Jan 29, 2018: Endologix Appoints Greg Morrow as Chief Marketing Officer 100

6.33 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 100

6.34 Jan 24, 2018: Medtronic Launches ENCHANT Study to Evaluate ChEVAR Parallel Graft Technique with the Endurant(TM) II/IIs Stent Graft System 102

6.35 Jan 11, 2018: Vizient to Share GPO Insights on Medical Device Cybersecurity at Jan. 16 Conference 103

6.36 Jan 08, 2018: Altura Endograft System Granted CFDA Green-Path 104

6.37 Jan 08, 2018: MicroPort Endovascular Attends CEC 2017 104

6.38 Jan 08, 2018: Lombard Medical Announces Update on its Loan and Security Agreement 106

6.39 Jan 03, 2018: First Patient Enrolled in Investigational Study of the GORE EXCLUDER Conformable AAA Endoprosthesis with ACTIVE CONTROL System 106

6.40 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 107

6.41 Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems 108

6.42 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 109

6.43 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 111

6.44 Nov 07, 2017: Endologix Reports Third Quarter 2017 Financial Results 112

6.45 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 113

6.46 Oct 31, 2017: Lombard Medical Reports First Half and Third Quarter 2017 Financial Results 114

6.47 Oct 26, 2017: LeMaitre Q3 2017 Sales USD24.8mm (+7%), Record EPS USD0.25 (+49%) 116

6.48 Oct 19, 2017: Endologix Appoints John Onopchenko as Chief Operating Officer 116

6.49 Oct 10, 2017: Terumo Provides Update on Impact from Hurricane Maria 117

6.50 Oct 09, 2017: Medtronic Endurant II/IIs Stent Graft System Receives FDA Approval to Treat Short Neck Anatomies When Used with Heli-FX EndoAnchor System 117

6.51 Oct 06, 2017: Endologix Receives IDE Approval for the EVAS2 Confirmatory Clinical Study to Evaluate the Nellix EndoVascular Aneurysm Sealing System 118

6.52 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 119

6.53 Oct 03, 2017: Vizient Names New President and CEO 120

6.54 Oct 02, 2017: Celebrating the 20th Anniversary of the GORE EXCLUDER Device 121

6.55 Sep 26, 2017: Vizient Announces Stephen Downey in Newly Created Role of Group Senior Vice President of Supply Chain Operations 122

6.56 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California 122

6.57 Sep 21, 2017: Endologix Announces CE Mark Approval for the Nellix EndoVascular Aneurysm Sealing System with the Refined Indications for Use 123

6.58 Sep 20, 2017: Lombard Medical Appoints Jonathan Hornsby as Vice President, Sales & Marketing 124

6.59 Sep 13, 2017: New Five-Year Gender Subset Data from the Medtronic Engage Registry Presented in VIVA Late Breaking Trials 124

6.60 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY 125

6.61 Sep 11, 2017: Vizient Deeply Concerned that Proposed CMS Rules Will Harm Hospitals and Negatively Impact Patient Care 127

6.62 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 127

6.63 Aug 17, 2017: Endologix Announces Positive Clinical Results from the LEOPARD Clinical Study 130

6.64 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 131

6.65 Aug 02, 2017: Endologix Reports Second Quarter 2017 Financial Results 131

6.66 Jul 27, 2017: LeMaitre Q2 2017 Record Sales USD25.8 mm (+15%), Record EPS USD0.23 (+69%) 132

6.67 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 133

6.68 Jul 21, 2017: Bolton Medical Announces the First Implant in the TREO Global Registry 133

6.69 Jul 07, 2017: MPSC New COO Glendy Wang on Board 134

7 Appendix 135

7.1 Methodology 135

7.2 About GlobalData 138

7.3 Contact Us 138

7.4 Disclaimer 138

1.2 List of Figures

Figure 1: Abdominal Aortic Stent Grafts-Pipeline Products by Stage of Development 10

Figure 2: Abdominal Aortic Stent Grafts-Pipeline Products by Territory 11

Figure 3: Abdominal Aortic Stent Grafts-Pipeline Products by Regulatory Path 13

Figure 4: Abdominal Aortic Stent Grafts-Pipeline Products by Estimated Approval Date 14

Figure 5: Abdominal Aortic Stent Grafts-Ongoing Clinical Trials 15

1.1 List of Tables

Table 1: Abdominal Aortic Stent Grafts-Pipeline Products by Stage of Development 10

Table 2: Abdominal Aortic Stent Grafts-Pipeline Products by Territory 11

Table 3: Abdominal Aortic Stent Grafts-Pipeline Products by Regulatory Path 13

Table 4: Abdominal Aortic Stent Grafts-Pipeline Products by Estimated Approval Date 14

Table 5: Abdominal Aortic Stent Grafts-Ongoing Clinical Trials 15

Table 6: Abdominal Aortic Stent Grafts Companies-Pipeline Products by Stage of Development 16

Table 7: Abdominal Aortic Stent Grafts-Pipeline Products by Stage of Development 17

Table 8: Altura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Table 9: Altura Endograft System-Product Status 19

Table 10: Altura Endograft System-Product Description 19

Table 11: Altura Medical Inc-Ongoing Clinical Trials Overview 20

Table 12: Altura Endograft System-Kissing Endografts for Peripheral AAA Exclusion (ELEVATEInternational) 21

Table 13: Altura Endograft System-Multi-center Observational Post-market Real World Registry 21

Table 14: Altura Endograft System-The Altura AAA Endograft Safety and Feasibility Study For Exclusion of Abdominal Aortic Aneurysms 21

Table 15: BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

Table 16: Stainless Steel Nitinol Two-Way Shape Memory Stent-Product Status 22

Table 17: Stainless Steel Nitinol Two-Way Shape Memory Stent-Product Description 22

Table 18: Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 23

Table 19: Zenith p-Branch-Product Status 23

Table 20: Zenith p-Branch-Product Description 23

Table 21: Cook Medical Inc-Ongoing Clinical Trials Overview 24

Table 22: Zenith p-Branch-Evaluation of Visceral Function Following Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR) Using Branch Stent-Grafts 25

Table 23: Zenith p-Branch-Study Assessing Safety and Effectiveness of Perivisceral Aortic Aneurysm Treatment with the Zenith Fenestrated AAA Endovascular Graft and the Zenith p-Branch and the Effects on Organ and Extremity Perfusion 25

Table 24: Zenith p-Branch-Zenith p-Branch Multi-center Study 25

Table 25: Zenith p-Branch-Zenith p-Branch Pivotal Study 26

Table 26: Zenith p-Branch-Zenith p-Branch: Single-center Study 26

Table 27: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 27

Table 28: INCRAFT AAA Stent Graft-Product Status 27

Table 29: INCRAFT AAA Stent Graft-Product Description 27

Table 30: Cordis Corp-Ongoing Clinical Trials Overview 28

Table 31: INCRAFT AAA Stent Graft-A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft Stent Graft System in Subjects With Abdominal Aortic Aneurysms: INSPIRATION 29

Table 32: INCRAFT AAA Stent Graft-A Multicenter, Open Label, Prospective, Post Approval Study of the INCRAFT Abdominal Aortic Aneurysm (AAA) Stent Graft System in Subjects with Abdominal Aortic Aneurysms 29

Table 33: INCRAFT AAA Stent Graft-Compassionate Use of the Incraft AAA Stent Graft System 29

Table 34: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30

Table 35: LifeJacket AAA Stent Graft-Product Status 30

Table 36: LifeJacket AAA Stent Graft-Product Description 30

Table 37: Endologix Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Table 38: AFX2 Bifurcated Endograft System-Product Status 31

Table 39: AFX2 Bifurcated Endograft System-Product Description 32

Table 40: AFX3-Product Status 32

Table 41: AFX3-Product Description 32

Table 42: AFX4-Product Status 33

Table 43: AFX4-Product Description 33

Table 44: Nellix CHEVAS-Product Status 33

Table 45: Nellix CHEVAS-Product Description 34

Table 46: Nellix EVAS System-Product Status 34

Table 47: Nellix EVAS System-Product Description 34

Table 48: Nellix With Snorkels-Product Status 35

Table 49: Nellix With Snorkels-Product Description 35

Table 50: Nellix2 AAA Endovascular System-Product Status 35

Table 51: Nellix2 AAA Endovascular System-Product Description 35

Table 52: Ovation Alto Abdominal Stent Graft System-Product Status 36

Table 53: Ovation Alto Abdominal Stent Graft System-Product Description 36

Table 54: Paravisceral System-Product Status 36

Table 55: Paravisceral System-Product Description 36

Table 56: Ventana 2-Product Status 37

Table 57: Ventana 2-Product Description 37

Table 58: Xpand BX Covered Stent-Product Status 37

Table 59: Xpand BX Covered Stent-Product Description 37

Table 60: Endologix Inc-Ongoing Clinical Trials Overview 38

Table 61: Nellix EVAS System-Multicenter, Observational, Registry to Assess Outcomes of Patients Treated With the CE Marked Nellix System for Endovascular Abdominal Aortic Aneurysm Repair 39

Table 62: Nellix EVAS System-Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System IDE Study: EVAS 2 Confirmatory IDE Study 39

Table 63: Nellix EVAS System-Prospective, Multicenter, Single Arm Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System: A Pivotal and Continued Access Study 39

Table 64: Nellix EVAS System-Study of a Sealing Type Stent-graft For Abdominal Aortic Aneurysm 40

Table 65: Xpand BX Covered Stent-Prospective, Multicenter, Single Arm Feasibility and Safety Study of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms 41

Table 66: Nellix2 AAA Endovascular System-Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System IDE Study: EVAS 2 Confirmatory IDE Study 42

Table 67: Ovation Alto Abdominal Stent Graft System-Expanding Patient Applicability with Polymer Sealing Ovation Alto Stent Graft IDE Study 43

Table 68: Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview 44

Table 69: Stent-Graft With Adhesive Delivery Platform-Product Status 44

Table 70: Stent-Graft With Adhesive Delivery Platform-Product Description 44

Table 71: Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 45

Table 72: In Situ Weldable Hybrid Stent-Product Status 45

Table 73: In Situ Weldable Hybrid Stent-Product Description 45

Table 74: Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 46

Table 75: Abdominal Aortic Aneurysm Stent Graft-Product Status 46

Table 76: Abdominal Aortic Aneurysm Stent Graft-Product Description 46

Table 77: Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

Table 78: Ankura II AAA Stent Graft-Product Status 47

Table 79: Ankura II AAA Stent Graft-Product Description 47

Table 80: Iliac Bifurcation Stent Graft System-Product Status 48

Table 81: Iliac Bifurcation Stent Graft System-Product Description 48

Table 82: Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 49

Table 83: Aorfix Plus Endovascular Stent Graft-Product Status 49

Table 84: Aorfix Plus Endovascular Stent Graft-Product Description 49

Table 85: FEVAR-Product Status 50

Table 86: FEVAR-Product Description 50

Table 87: Lombard Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

Table 88: Aorfix Flexible Stent Graft System-Product Status 51

Table 89: Aorfix Flexible Stent Graft System-Product Description 51

Table 90: Low Profile Stent Graft-Product Status 52

Table 91: Low Profile Stent Graft-Product Description 52

Table 92: Lombard Medical Technologies Ltd-Ongoing Clinical Trials Overview 53

Table 93: Aorfix Flexible Stent Graft System-AAA Registry: Clinical Outcomes of Highly Angulated Anatomy Treated with the Aorfix Stent Graft (ARCHYTAS) 54

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Altura Medical Inc

BiFlow Medical Ltd

Cook Medical Inc

Cordis Corp

Cytograft Tissue Engineering Inc

Endologix Inc

Endoluminal Sciences Pty Ltd.

Hadassah Medical Center

Kawasumi Laboratories Inc

Lifetech Scientific (Shenzhen) Co Ltd

Lombard Medical Technologies Inc.

Lombard Medical Technologies Ltd

Medtronic plc

MicroPort Scientific Corp

St. Jude Medical LLC

Terumo Aortic

TriVascular Inc

University of Colorado Denver

University of Limerick

Venus MedTech

W. L. Gore & Associates Inc

Altura Medical Inc, Altura Endograft System; BiFlow Medical Ltd, Stainless Steel Nitinol Two-Way Shape Memory Stent; Cook Medical Inc, Zenith p-Branch; Cordis Corp, INCRAFT AAA Stent Graft; Cytograft Tissue Engineering Inc (Inactive), LifeJacket AAA Stent Graft; Endologix Inc, AFX2 Bifurcated Endograft System; Endologix Inc, AFX3; Endologix Inc, AFX4; Endologix Inc, Nellix CHEVAS; Endologix Inc, Nellix EVAS System; Endologix Inc, Nellix With Snorkels; Endologix Inc, Nellix2 AAA Endovascular System; Endologix Inc, Ovation Alto Abdominal Stent Graft System; Endologix Inc, Paravisceral System; Endologix Inc, Ventana 2; Endologix Inc, Xpand BX Covered Stent; Endoluminal Sciences Pty Ltd., Stent-Graft With Adhesive Delivery Platform; Hadassah Medical Center, In Situ Weldable Hybrid Stent; Kawasumi Laboratories Inc, Abdominal Aortic Aneurysm Stent Graft; Lifetech Scientific (Shenzhen) Co Ltd, Ankura II AAA Stent Graft; Lifetech Scientific (Shenzhen) Co Ltd, Iliac Bifurcation Stent Graft System; Lombard Medical Technologies Inc., Aorfix Plus Endovascular Stent Graft; Lombard Medical Technologies Inc., FEVAR; Lombard Medical Technologies Ltd, Aorfix Flexible Stent Graft System; Lombard Medical Technologies Ltd, Low Profile Stent Graft; Medtronic plc, Endurant Evo AAA Stent Graft System; MicroPort Scientific Corp, Minos Ultra Low Profile Abdominal Aortic Aneurysm Stent-Graft System; St. Jude Medical LLC, Amplatzer AAA Vascular Graft; Terumo Aortic, Next Generation Anaconda LP Stent Graft; Terumo Aortic, TREO Abdominal Stent-Graft System; Terumo Aortic, TREO Aorto-Uni-Iliac Abdominal Stent-Graft System; Terumo Aortic, Treovance Abdominal Stent Graft With Navitel Delivery System; TriVascular Inc, Ovation Alto System; TriVascular Inc, Ovation IX Abdominal Stent Graft System; University of Colorado Denver, Shape Memory Polymer Arterial Stent; University of Limerick, Cardiovascular Graft; Venus MedTech, Tumbao EndoVascular Aortic Repair System; W. L. Gore &; Associates Inc, GORE EXCLUDER Conformable AAA Endoprosthesis

select a license
Single User License
USD 4000 INR 280000
Site License
USD 8000 INR 560000
Corporate User License
USD 12000 INR 840000

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com